Whitehawk Therapeutics Inc

WHWK · Nasdaq

Whitehawk Therapeutics Inc (WHWK) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Whitehawk Therapeutics Inc in 2026. The next earnings report is expected on November 11, 2026.

Earnings calendar

Next earnings date

11 Nov 2026

In 83 days

EPS estimate

-0.24

Revenue estimate

-383.3K

Past earnings

Date	EPS actual	Revenue actual	1d	5d	30d
06 Aug 2026	-0.20 (+32.4%) estimate -0.30	0 (+100.0%) estimate -350.0K	+2.37%	-2.41%	+4.37%
07 May 2026	-0.32 (+10.5%) estimate -0.36	0 estimate 0	+2.37%	-2.41%	+4.37%
12 Mar 2026	-0.34 (+29.5%) estimate -0.48	0 estimate 0	+2.37%	-2.41%	+4.37%
06 Nov 2025	-0.26 (-490.0%) estimate 0.07	0 estimate 0	+2.37%	-2.41%	+4.37%

06 Aug 2026

EPS actual

-0.20 (+32.4%)

estimate -0.30

Revenue actual

0 (+100.0%)

estimate -350.0K

Price reaction

+2.37%

-2.41%

30d

+4.37%

07 May 2026

EPS actual

-0.32 (+10.5%)

estimate -0.36

Revenue actual

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

12 Mar 2026

EPS actual

-0.34 (+29.5%)

estimate -0.48

Revenue actual

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

06 Nov 2025

EPS actual

-0.26 (-490.0%)

estimate 0.07

Revenue actual

estimate 0

Price reaction

+2.37%

-2.41%

30d

+4.37%

Beat Miss usd

Latest earnings analysis

Whitehawk Therapeutics Inc beat consensus estimates in its latest earnings report, with EPS of USD -0.2 beating the estimate of USD -0.2957 and revenue of USD 0 exceeding the estimate of USD -350 thousand, or 100.0% above expectations. In the prior quarter, EPS also came in ahead of expectations while revenue met estimates.

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Whitehawk Therapeutics Inc operates as a clinical-stage biopharmaceutical company. The Company develops precision therapies for genetically-defined cancers.

Sector: Healthcare
Industry: Biotechnology
Country: United States
Exchange: Nasdaq
CEO: David J. Lennon
Employees: 40
IPO date: 01 Aug 2017
ISIN: US00032Q1040
Website: ir.whitehawktx.com

Frequently asked questions

When does Whitehawk Therapeutics Inc (WHWK) next report earnings?

Whitehawk Therapeutics Inc (WHWK) is scheduled to report earnings on November 11, 2026.

What was Whitehawk Therapeutics Inc's most recent earnings date?

Whitehawk Therapeutics Inc (WHWK) last reported earnings on August 6, 2026.

Where is Whitehawk Therapeutics Inc stock listed?

Whitehawk Therapeutics Inc (WHWK) is listed on Nasdaq.